Molly Harper, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 10,666 shares at $16.30 ($174K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Open-market sale of $174k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.30 | 5,333 | $87K | 50.0% |
| 2 | $16.30 | 5,333 | $87K | 50.0% |
| Total | $16.30 avg | 10,666 | $174K | 100% |
| Filing → |
| CPRX | SELL | 2023-12-19 | $201K | — | Filing → |